glp-1 and migraine A drug originally designed to treat obesity is now showing surprising promise in the fight against migraines. In a recent early-stage clinical trial, the receptor agonist liraglutide from the same family GLP-1 drugs associated with reduced

Eating enough protein when your appetite is the size of a walnut

Metformin biodistribution: a key to mechanisms of action

The Wegovy label reports that kidney injury "occurred more frequently during dose titration" (the step-up period) and advises monitoring kidney function "especially during dosage initiation and escalation." That lines up with how the side effects behave

Additionally, people affected by certain medical conditions, such as (but not limited to) those listed below, can find incredibly beneficial improvements to their lives and the condition they are facing

Compounded semaglutide and compounded tirzepatide follow the same storage guidelines as their brand-name counterparts but always check the label from your pharmacy

A.IversenN.HjeltnesN.sterudB.SandsetP